BMO Capital Maintains Outperform on Constellium, Lowers Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Katja Jancic maintains an Outperform rating on Constellium (NYSE:CSTM) but lowers the price target from $24 to $22.
October 10, 2024 | 4:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BMO Capital has maintained its Outperform rating on Constellium but has lowered the price target from $24 to $22, indicating a slightly less optimistic outlook.
The maintenance of an Outperform rating suggests continued confidence in Constellium's performance, but the lowered price target indicates a tempered outlook, likely leading to a slight negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100